Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression

Frontiers in Psychiatry

Volumn 3, Issue FEB, 2012, Pages

  Gedge, Laura ^a,b   Beaudoin, Ashley ^a   Lazowski, Lauren ^a   du Toit, Regina ^c   Jokic, Ruzica ^c,d   Milev, Roumen ^c,d  

^a QUEEN S UNIVERSITY   (Canada)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^c QUEEN S UNIVERSITY   (Canada)

^d Providence Continuing Care Centre   (Canada)

Author keywords

Brain derived neurotrophic factor; Depression; Electroconvulsive therapy; Repetitive transcranial magnetic stimulation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; ELECTROCONVULSIVE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PILOT STUDY; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REPETITIVE TRANSCRANIAL MAGNETIC STIMULATION; SINGLE BLIND PROCEDURE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE;

EID: 84866851270     PISSN: None     EISSN: 16640640     Source Type: Journal    
DOI: 10.3389/fpsyt.2012.00012     Document Type: Article

References (56)

1. Alderson, R. F., Alterman, A. L., Barde, Y. A., and Lindsay, R. M. (1990). Brain-derived neurotrophic factor increases survival and differentiated functions of rat septal choliner-gic neurons in culture. Neuron 5, 297-306.
2. Altar, C. A., Whitehead, R. E., Chen, R., Wörtwein, G., and Madsen, T. M. (2003). Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biol. Psychiatry 54, 703-709.
3. Angelucci, F., Aloe, L., Jiménez-Vasquez, P.,andMathé,A. (2002).Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J. ECT 18, 138-143.
4. Angelucci, F., Brene, S., and Mathe, A. A. (2005). BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry 10, 345-352.
5. Aydemir, O., Deveci, A., and Taneli, E (2005). The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Prog. Neuropsy-chopharmacol Biol. Psychiatry 29, 261-265.
6. Bocchio-Chiavetto, L., Bagnardi, V., Zanardini, R., Molteni, R., Nielsen, M. G., Placentino, A., and Giovan-nini, C. (2010). Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. WorldJ. Biol. Psychiatry 11, 763-773.
7. Bocchio-Chiavetto, L., Zanardini, R., Bortolomasi, M., Abate, M., Segala, M., Giacopuzzi, M., Riva, M. A., Marchina, E., Pasqualetti, P., Perez, J., and Gennarelli, M. (2006). Electro-convulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant patients. Eur. Neuropsychopharmacol. 16, 620-624.
8. Bremner, J. D., Narayan, M., Anderson, E R., Staib, L. H., Miller, H. L., and Charney, D. S. (2000). Hippocampal volume reduction in major depres sion. Am.J. Psychiatry 157,115-118.
9. Brunoni, A. R., Lopes, M., and Fregni, F. (2008). A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuro-plasticity in depression. Int. J. Neu-ropsychopharmacol. 11, 1169-1180.
10. Chen, B., Dowlatshahi, D., Mac-Queen, G., Wang, J., and Young, L. T. (2001). Increased hippocampal bdnf immunoreactivity in subjects treated with antidepressant medication. Biol Psychiatry 50, 260-265.
11. Eaton, M. J., and Whittemore, S. R. (1996). Autocrine BDNF secretion enhances the survival and serotoner-gic differentiation of raphe neuronal precursor cells grafted into the adult rat CNS. Exp. Neurol. 140, 105-114.
12. Elfving, B., Plougmann, P. H., Müller, H. K., Mathé, A. A., Rosenberg, R., and Wegener, G. (2010). Inverse correlation of brain and blood BDNF levels in a genetic rat model of depression. Int. J. Neuropsychopharmacol. 13, 563-572.
13. Fernandes, B., Gama, C. S., Massuda, R., Torres, M., Camargo, D., Kunz, M., Belmonte-de-Abreu, P. S., Kapczinski, F., de Almeida Fleck, M. P., and Inês Lobato, M. (2009). Serum brain derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neu-rosci. Lett. 453, 195-198.
14. Gershon, A. A., Dannon, P. N., and Grunhaus, L. (2003). Transcranial magnetic stimulation in the treatment of depression. Am. J. Psychiatry 160, 835-845.
15. Gervasoni, N., Aubry, J. M., Bon-dolfi, G., Osiek, C., Schwald, M., Bertschy, G., and Karege, F. (2005). Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiol-ogy 51, 234-238.
16. Ghosh, A., Carnahan, J., and Green-berg, M. E. (1994). Requirement for BDNF in activity-dependent survival of cortical neurons. Science 263, 1618-1623.
17. Gonul, A. S., Akedeniz, F., Taneli, F., Donat, O., Eker, C., and Vahip, S. (2005). Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur. Arch. Psychiatry Clin. Neurosci. 255, 381-386.
18. Gronli, O., Stensland, G. Ø., Wynn, R., and Olstad, R. (2009). Neurotrophic factors in serum following ECT: a pilot study. World J. Biol Psychiatry 10, 295-301.
19. Hashimoto, K., Shimizu, E., and Iyo, M. (2004). Critical role of brain-derived neurotrophic factor in mood disorders. Brain Res. Rev. 45, 104-114.
20. Hellweg, R., Ziegenhorn, A., Heuser, I., and Deuschle, M. (2008). Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment. Pharmacopsychiatry 41, 66-71.
21. Hoffman, R. E., and Cavus, I. (2002). Slow transcranial magnetic stimulation, long-term depotentiation, and brain hyperexcitability disorders. Am.J. Psychiatry 159, 1093-1102.
22. Hu, Y., Yu, X., Yang, F., Si, T., Wang, W., Tan, Y., Zhou, D., Wang, H., and Chen, D. (2010). The level of serum brain-derived neurotrophic factor is associated with the therapeutic efficacy of modified electroconvulsive therapy in Chinese patients with depression.J. ECT26, 121-125.
23. Huang, T. L., Lee, C. T., and Liu, Y. L. (2007). Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J. Psychiatr. Res. 45, 521-525.
24. Hyman, C., Hofer, M., Barde, Y. A., Juhasz, M., Yancopoulos, G. D., and Squinto, S. P. (1991). BDNF is a neurotrophic factor for dopaminer-gic neurons of the substantia nigra. Nature 350, 230-232.
25. Kaplan, D. R., and Miller, F. D. (2000). Neurotrophin signal transduction in the nervous system. Curr. Opin. Neu-robiol. 10, 381-391.
26. Karege, F., Bondolfi, G., Gervasoni, N., Schwald, M., Aubry, J. M., and Bertschy, G. (2005). Low brain derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57, 1068-1072.
27. Karege, F., Perret, G., Bondolfi, G., Schwald, M., Bertschy, G., and Aubry, J. M. (2002a). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res. 109, 143-148.
28. Karege, F., Schwald, M., and Cisse, M. (2002b). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci. Lett. 328, 261-264.
29. Klein, A. B., Williamson, R., Santini, M., Clemmensen, C., Ettrup, A., Rios, M., Knudsen, G. M., and Aznar, S. (2010). Blood BDNF concentrations reflect brain tissue BDNF levels across species. Int. J. Neuropsychopharmacol. 7, 1-7.
30. Lang, U. E., Bajbouj, M., Galli-nat, J., and Hellweg, R. (2006). Brain-derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacol-ogy (Berl.) 187, 56-59.
31. Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Maetzler, W., Wit-torf, A., Soekadar, S., Richartz, E., Koehler, N., Bartels, M., Buchkre-mer, G., and Schott, K. (2007). BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. J. Psychiatr. Res. 41, 387-394.
32. Lee, B. H., Kim, H., Park, S. H., and Kim, Y. K. (2007). Decreased plasma BDNF level in depressive patients. J. Affect. Disord. 101, 239-244.
33. Lindholm, D., Carroll, P., Tzimagio-gis, G., and Thoenen, H. (1996). Autocrine-paracrine regulation of hippocampal neuron survival by IGF-1 and the neurotrophins BDNF, NT-3 and NT-4. Eur. J. Neurosci. 8, 1452-1460.
34. Lisanby, S. H. (2007). Electroconvulsive therapy for depression. N. Eng. J. Med. 357, 1939-1945.
35. Marano, C. M., Phatak, P., Vemyla-palli, U. R., Sasan, A., Nalbandyan, M. R., Ramanujam, S., Soekadar, S., Demosthenous, M., and Regenold, W T. (2007). Increased plasma concentration of brain-derived neurotrophic factor with electroconvulsive therapy: a pilot study in patients with major depression. J. Clin. Psychiatry 68, 512-517.
36. Matrisciano, F., Bonaccorso, S., Riccia-rdi, A., Scaccianoce, S., Panaccione, I., Wang, L., Ruberto, A., Tatarelli, R., Nicoletti, F., Girardi, P., and Shel-ton, R. C. (2009). Changes in BDNF serum levels in patients with depression disorder (MDD) after 6 months treatment with sertraline, escitalo-pram, or venlafaxine. J. Psychiatr. Res. 43, 247-254.
37. Monteleone, P., Serritella, C., Martiadis, V., and Maj, M. (2008). Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 10, 95-100.
38. Okamoto, T., Yoshimura, R., Ikenouchi-Sugita, A., Hori, H., Umene-Nakano, W., Inoue, Y., Ueda, N., and Naka-mura, J. (2008). Efficacy of electroconvulsive therapy is associated with changingbloodlevels of homovanil-lic acid and brain derived neurotrophic factor (BDNF) in refractory depressed patients: a pilot study. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 1185-1190.
39. Piccini, A., Del Debbio, A., Medda, P., Bianchi, C., Roncaglia, I., Vel-tri, A., Zanello, S., Massimetti, E., Origlia, N., Domenici, L., Marazziti, D., and Dell'Osso, L. (2009). Plasma brain-derived neurotrophic factor in treatment-resistant depressed patients receiving electroconvulsive therapy. Eur. Neuropsychopharmacol. 19, 349-355.
40. Piccinni, A., Marazziti, D., Catena, M., Domenici, L., Del Debbio, A., Bianchi, C., Mannari, C., Martini, C., Da Pozzo, E., Schiavi, E., Mariotti, A., Roncaglia, I., Palla, A., Consoli, G., Giovannini, L., Massimetti, G., and Dell'Osso, L. (2008). Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J. Affect. Disord. 105, 279-283.
41. Promega. (2009). Technical Bulletin: BDNF Emax ®ImmunoAssay System. Available at: www.promega.com/ tbs/tb257/tb257.html
42. Rossini, P. M., Barker, A. T., Berardelli, A., Caramia, M. D., Caruso, G., Cracco, R. Q., Dimitrijevic, M. R., Hallett, M., Katayama, Y., Lucking, C. H., Maertens de Noordhout, A. L., Marsden, C. D., Murray, N. M. E, Rothwell, J. C., Swash, M., and Tomberg, C. (1994). Non-invasive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroen-cephalogr. Clin. Neurophysiol. 91, 79-92.
43. Russo-Neustadt, A. A., and Chen, M. J. (2005). Brain-derived neurotrophic factor and antidepressant activity. Curr. Pharm. Des. 11, 1495-1510.
44. Sapolsky, R. M. (1996). Why stress is bad for your brain. Science 273, 749-750.
45. Sartorius, A., Hellweg, R., Litzke, J., Vogt, M., Dormann, C., Vollmayr, B., Danker-Hopfe, H., and Gass, P. (2009). Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electro-convulsive treatment in rats. Phar-macopsychiatry 42, 270-276.
46. Schlaepfer, T. E., Kosel, M., and Nemeroff, C. B. (2003). Efficacy of repetitive transcranial magnetic stimulation (rTMS) in the treatment of affective disorders. Neu-ropsychopharmacology 28, 201-205.
47. Schmidt, H. D., and Duman, R. S. (2010). Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35, 2378-2391.
48. Sen, S., Duman, R., and Sanacora, G. (2008). Serum brain-derived neu-rotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol. Psychiatry 64, 527-532.
49. Sheline, Y. I., Sanghavi, M., Mintun, M. A., and Gado, M. H. (1999). Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. J. Neu-rosci. 19, 5034-5043.
50. Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., and Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proc. Natl. Acad. Sci. U.S.A. 93, 3908-3913.
51. Shimizu, E., Hashimoto, K., Oka-mura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watan-abe, H., Shinoda, N., Okada, S., and Iyo, M. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol. Psychiatry 54, 70-75.
52. Tamminga, C. A., Nemeroff, C. B., Blakely, R. D., Brady, L., Carter, C. S., Davis, K. L., Dingledine, R., Gorman, J. M., Grigoriadis, D. E., Henderson, D. C., Innis, R. B., Killen, J., Laughren, T. P., McDonald, W. M., Murphy, G. M. Jr, Paul, S. M., Rudorfer, M. V., Sausville, E., Schatzberg, A. F., Scolnick, E. M., and Suppes, T. (2002). Developing novel treatments for mood disorders: accelerating discovery. Biol Psychiatry 52, 589-609.
53. Warner-Schmidt, J. L., and Duman, R. S. (2006). Hippocampal neurogenesis: opposing effects of stress and anti-depressant treatment. Hippocampus 16, 239-249.
54. Yoshimura, R., Mitoma, M., Sugita, A., Hori, H., Okamoto, T., Umene, W., Ueda, N., and Nakamura, J. (2007). Effects of paroxetine or mil-nacipran on serum brain-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharma-col. Biol. Psychiatry 31, 1034-1037.
55. Yukimasa, T., Yoshimura, R., Tama-gawa, A., Uozumi, T., Shinkai, K., Ueda, N., Tsuji, S., and Nakamura, J. (2006). High frequency repetitive transcranial magnetic stimulation improves refractory depression by influencing catecholamine and brain-derived neurotrophic factors. Pharmacopsychiatry 39, 52-59.
56. Zanardini, R., Gazzoli, A., Ventriglia, M., Perez, J., Bignotti, S., Rossini, P. M., Gennarelli, M., and Bocchio-Chiavetto, L. (2006). Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. J. Affect. Disord. 91, 83-86.